systemic immune response
[용어속성] Action
Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and Mis-C
Article
[키워드] acute COVID-19
Antibody Response
Beta
children
circulating
coronavirus disease
COVID-19
evaluated
Gamma
Immunity
implication
Inflammatory
information
Iota
Lower
Lower respiratory tract
MIS-C
mucosal
mucosal immunity
neutralization
neutralizing antibody
Neutralizing antibody response
Neutralizing titer
omicron
Patient
patients
pediatric
plasma
Re-infection
respiratory
SARS-CoV-2
SARS-CoV-2 variants
SARS-CoV-2 WA1/2020
severe COVID-19
syndrome
systemic
systemic immune response
the SARS-CoV-2
Trachea
tract
variants
variants of concern
variants of interest
viral respiratory infection
VoC
VOCs
VOIs
WA1/2020
while
[DOI] 10.3390/vaccines10020270 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/vaccines10020270 PMC 바로가기 [Article Type] Article
Collapsing Focal Segmental Glomerulosclerosis in Viral Infections
바이러스 감염에서 국소 분절 사구체 경화증의 붕괴
Review
[키워드] activated
Acute kidney injury
acute viral infection
acute viral infections
African
AKI
APOL 1
APOL1
appearance
Capillaries
cascade
cellular
characterized
Collapsing
contributing to
COVAN
COVID-19
cytokine
cytomegalovirus
described
direct viral infection
drug
epithelial cells
etiologies
Evidence
Focal
focal segmental glomerulosclerosis
focus
function
glomerular
glomerular capillaries
glomerulopathy
glomerulosclerosis
hemodynamic instability
high risk
HIV
HIVAN
hyperplastic
hypertrophic
immune response
immune responses
impairment
Infection
Injury
Ischemia
kidney
Kidney disease
Kidney failure
knowledge
obliteration
Pathogenesis
Patient
podocyte
Podocytes
potential mechanism
potential mechanisms
progression
Proteinuria
renal epithelial cell
risk
SARS-CoV-2
SARS-COV-2 infection
Segmental
Severe case
severe cases
systemic immune response
systemic immune responses
systemic inflammatory
variant
Viral
viral entry
viral infection
viral infections
[DOI] 10.3389/fimmu.2021.800074 PMC 바로가기 [Article Type] Review
[DOI] 10.3389/fimmu.2021.800074 PMC 바로가기 [Article Type] Review
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
BNT162b2 COVID-19 백신 수혜자의 점막 면역 반응
Clinical Trial
[키워드] acquisition
activated
Antibody titre
baseline
BNT162b2
BNT162b2 mRNA
BNT162b2 mRNA vaccine
collected
Concentration
COVID-19
COVID-19 vaccine
Department
elicit
ELISA
entry of SARS-CoV-2
first dose
generate
healthcare worker
highest
IgA
IgG
immune response
Immunity
increase
induce
magnitude
Medicine
mRNA BNT162b2
much higher
mucosal
neutralizing antibody
protocol
Quantitative
recipient
Saliva
Sample
SARS-CoV-2
second dose
seronegative
seropositive individual
seropositive individuals
seropositive subjects
serum
serum IgG
significantly
single dose
subjects
supported
surgery
systemic immune response
titre
total antibody
Umberto
university
vaccination
vaccine dose
virus
were measured
[DOI] 10.1016/j.ebiom.2021.103788 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1016/j.ebiom.2021.103788 PMC 바로가기 [Article Type] Clinical Trial
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak
Observational Study
[키워드] Activation
Angiogenesis
antibody
Biomarker
Blood
Cell
characterized
chilblain
clinical manifestations
CLL
complement
conducted
COVID-19 outbreak
COVID-19 pandemic
cytoplasmic
defined
elevated
endothelial
Endothelial dysfunction
excluded
exclusion
Factor
France
gene signature
groups
healthy control
healthy controls
IgA
immune infiltration
immune system
interferon response
lesion
outbreak
overlapped
Paris
pathophysiology
Patient
patients
reported
SARS-COV-2 infection
Support
systemic immune response
tissue
transcriptomic
Type
type I
type I interferon
Vascular
[DOI] 10.1111/bjd.20707 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1111/bjd.20707 PMC 바로가기 [Article Type] Observational Study
Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis
Medicine
[키워드] Absolute lymphocyte count
absolute neutrophil count
acute respiratory syndrome
addition
Affect
alpha-2b
Asymptomatic
bilateral lung
bilateral lungs
Chest
China
cirrhosis
clinical
clinical feature
clinician
coronavirus
Coronavirus disease 2019
cough
COVID-19
COVID-19 patient
Cured patient
discharged
disease
Fever
global pandemic
homeostatic
hospital
immune system
impair
indicated
Infection
Inflammation
injection
Interaction
interferon
liver
Patient
PCR
plasma
polymerase chain
positive
preexisting comorbidity
remained
reported
reverse transcription
Ritonavir
rRT-PCR
SARS-CoV-2
shown
systemic immune response
Tablet
tested
the patient
therapeutic effect
treated
Treatment
WBC
White blood cell
Wuhan
[DOI] 10.3389/fmed.2021.678227 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.678227 PMC 바로가기 [Article Type] Medicine
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
MVA 벡터 백신의 비강 내 전달은 설치류의 SARS-CoV-2에 대한 효과적인 폐 면역을 유도합니다
Immunology
[키워드] Against
anti-spike antibodies
anti-spike antibody
Antigen
applied
approach
Booster vaccine
bronchus-associated lymphoid tissue (BALT)
CD4
CD8
component
delivery
effective
followed by
hamster
hamsters
identify
IgA
IgA antibodies
IgA antibody
immune responses
Immunity
immunization
induce
intramuscular
intranasal
Local
lung
Lung infection
Lungs
memory T
memory T cell
memory T cells
mice
modified vaccinia virus Ankara (MVA)
Neutralizing
Neutralizing antibodies
pathology
priming
PROTECT
protocol
protocols
pulmonary
respiratory
respiratory tract
rodent
SARS-CoV-2
SARS-CoV-2 infections
SARS-CoV-2 variant
SARS-CoV-2-S
serum
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
spike (S) protein
systemic immune response
systemic immune responses
T cell
T cells
tested
Th1
Th2
titers of IgG
treatment regimen
vaccination
Vaccine
vaccine candidate
vaccinia
vector
Viral
viral infections
virus
Virus neutralization
[DOI] 10.3389/fimmu.2021.772240 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.772240 PMC 바로가기 [Article Type] Immunology
Immune Response of Neonates Born to Mothers Infected With SARS-CoV-2
SARS-CoV-2에 감염된 산모에게서 태어난 신생아의 면역 반응
Observational Study
[키워드] 48 hour
48 hours
age
antibody
antibody production
arbitrary unit
association
Birth
breastmilk
children
Clinical outcome
cohort study
enrolled
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
evaluated
explain
exposure
exposure to
finding
Follow-up
gestational age
IgA
IgA antibodies
IgA antibody
IgG antibodies
IgM antibodies
IgM antibody
immune complex
Immune complexes
immune response
immune responses
immune system
Importance
in utero
Infant
Infants
infected with SARS-CoV-2
Infection
infection with SARS-CoV-2
information
investigated
IQR
Italy
life
male
Maternal
maternal age
measure
mother
mucosal
mucosal immune
Neonatal
Neonate
Newborn
objective
occurred
offspring
participant
parturition
passive immunity
Point
positive
Pregnancy
pregnant women
prospective cohort study
PROTECT
provided
Receptor binding
Receptor binding domain
Relevance
response
Result
Rome
Saliva
salivary
SARS-CoV-2
SARS-CoV-2 IgG
SARS-COV-2 infection
SARS-CoV-2 spike
secretory IgA
serum
setting
significantly higher
significantly increased
specific antibodies
specific antibody
specific IgG antibodies
spike-specific antibodies
Spike-specific antibody
spike-specific IgG
stimulate
systemic immune response
systemic immune responses
tested
transfer
Transmission
Umberto
vertical transmission
vertical virus transmission
virus
Virus spike
virus transmission
[DOI] 10.1001/jamanetworkopen.2021.32563 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1001/jamanetworkopen.2021.32563 PMC 바로가기 [Article Type] Observational Study
Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine Responses
Immunology
[키워드] Activation
Adaptive immune response
baseline
CCL4
chemokine
chemokines
Covaxin
COVID-19
CX3CL1
CXCL1
CXCL10
CXCL2
cytokine
Cytokines
GM-CSF
healthy volunteers
IFNs
IFNγ
IL-10
IL-12
IL-13
IL-17A
IL-1α
IL-1β
IL-2
IL-33
IL-4
IL-5
IL-6
IL-7
inactivated
induce
investigated
plasma
pro-inflammatory cytokine
recipients
response
robust
SARS-CoV-2
SARS-CoV-2 vaccine
systemic
systemic immune response
TNFα
Type
vaccination
Vaccine
virion
[DOI] 10.3389/fimmu.2021.752397 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.752397 PMC 바로가기 [Article Type] Immunology
SARS‐CoV‐2 targeting by RNAi and host complement inhibition: A two‐pronged subterfuge for COVID‐19 treatment
RNAi에 의한 SARS-CoV-2 표적화 및 숙주 보체 억제: COVID-19 치료를 위한 두 갈래의 속임수
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
approach
C3a
clinical manifestation
clinical manifestations
complement
Complement inhibitor
component
conjunction
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID‐19
COVID‐19 patients
curtail
cytokine
Cytokine storm
degrade
detrimental
Disease progression
disease progression and severity
downstream
effective
Evidence
exacerbate
gene regulation processes
globe
Host
immune responses
infections
information
inhibitor
knowledge
lack
less
Local
mitigate
molecules
ORF
Perspective
preventive measure
preventive measures
progression
Proinflammatory cytokine
protective immunity
Replication
required
respiratory
Result
RNA interference
RNAi
robust
SARS‐CoV‐2
severe acute respiratory syndrome Coronavirus
severity
Spread
suppress
symptomatic and asymptomatic
systemic immune response
systemic immune responses
the cytokine storm
transcript
transmissible variant
Treatment
vaccinate
Vaccine
variants
Viral
viral spread
viral/retroviral
virus
[DOI] 10.1002/iid3.549 PMC 바로가기 [Article Type] Review
[DOI] 10.1002/iid3.549 PMC 바로가기 [Article Type] Review